Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
159 Leser
Artikel bewerten:
(0)

Global Urology Guidewires Market to Grow at a CAGR of 6.52% by 2021 - Key Vendors are Boston Scientific, Terumo Medical, Cook Medical, Olympus America & C. R. Bard

DUBLIN, July 17, 2017 /PRNewswire/ --

The "Global Urology Guidewires Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global urology guidewires market to grow at a CAGR of 6.52% during the period 2017-2021.

The report, Global Urology Guidewires Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

The latest trend gaining momentum in the market is growing demand for nitinol-based guidewires. There is significant demand for nitinol-based guidewires when compared with stainless steel and polymers. Urological surgery involves frequent use of guidewires. More than 60% of all interventional urology procedures require guidewires. The materials used in guidewires play an important role as they offer several advantages. Nitinol alloy, which is made from nickel and titanium, provides benefit to the guidewire manufacturers to achieve unique characteristics while undergoing phase transformation when subjected to changes in temperature, mechanical loading, and external forces.

According to the report, one of the major drivers for this market is growing prevalence of urological disorders. The growing prevalence of urological disorders such as prostate cancer, bladder cancer, bladder prolapse, hematuria, erectile dysfunction (ED), painful bladder syndrome, overactive bladder, and prostatitis will increase the demand for urology guidewires globally. The treatment of all these urological diseases has become critical in the recent years, which has led to a higher rate of hospitalization. Prostate cancer is the second most common type of cancer among men after skin cancer.

Further, the report states that one of the major factors hindering the growth of this market is retrieval of lost guidewires. During urological surgeries, most therapeutic devices such as catheters and stents are guided through guidewires, which are selected based on the choice and recommendation of the surgeon according to the medical condition of the patient. The growth in the number of urological surgeries and the increasing technical difficulty in performing these procedures with new devices and complex techniques have increased the loss of foreign objects. Some serious and rare complications do occur during urological surgeries. One of the major issues is the loss of guidewires during surgeries.

Key vendors

  • Boston Scientific
  • Terumo Medical
  • Cook Medical
  • Olympus America
  • C. R. Bard

Other prominent vendors

  • Amecath
  • B. Braun Melsungen
  • Merit Medical Systems
  • Optimed Medizinische Instrumente
  • ROCAMED
  • SURGIMEDIK
  • Teleflex
  • UroMed
  • UROTECH

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by product

PART 07: Market segmentation by end-user

PART 08: Geographical segmentation

PART 09: Decision framework

PART 10: Drivers and challenges

PART 11: Market trends

PART 12: Competitive landscape

PART 13: Key vendor analysis

For more information about this report visit https://www.researchandmarkets.com/research/cpvz3k/global_urology

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

© 2017 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.